Voyageur Pharmaceuticals (TSXV:VM) EBIT : C$-1.30 Mil (TTM As of May. 2024)

Voyageur Pharmaceuticals EBIT Chart

Voyageur Pharmaceuticals Annual Data
	Trend	Dec14	Dec15	Nov16	Nov17	Nov18	Nov19	Nov20	Nov21	Nov22	Nov23
EBIT		Get a 7-Day Free Trial					-0.56	-1.12	-2.05	-1.75	-1.40

Voyageur Pharmaceuticals Quarterly Data
	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24
EBIT	Get a 7-Day Free Trial															-0.62	-0.13	-0.28	-0.33	-0.56

Competitive Comparison of Voyageur Pharmaceuticals's EBIT

For the Drug Manufacturers - Specialty & Generic subindustry, Voyageur Pharmaceuticals's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Voyageur Pharmaceuticals's EV-to-EBIT Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Voyageur Pharmaceuticals's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Voyageur Pharmaceuticals's EV-to-EBIT falls into.

Voyageur Pharmaceuticals EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in May. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.30 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals  (TSXV:VM) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Voyageur Pharmaceuticals's annualized ROC % for the quarter that ended in May. 2024 is calculated as:

where

Note: The Operating Income data used here is four times the quarterly (May. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Voyageur Pharmaceuticals's annualized ROC (Joel Greenblatt) % for the quarter that ended in May. 2024 is calculated as:

where Working Capital is:

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (May. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Voyageur Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyageur Pharmaceuticals EBIT Related Terms

Thank you for viewing the detailed overview of Voyageur Pharmaceuticals's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Voyageur Pharmaceuticals Business Description